Virginia Heart is the Top Enrolling Site in the United States for the Lp(a) HORIZON Trial

Congratulations to the Virginia Heart Research team including Therese Wilson, Claudia Diaz, Deanna Overbeck, Lynn Soderstrom and Dr. Tariq Haddad.  Virginia Heart is the Top Enrolling Site in the United States for Lp(a)HORIZON, a trial to assess the impact of lowering Lipoprotein(a) on major cardiovascular events in patients with cardiovascular disease.  

The Virginia Heart Research Center, led by Dr. Tariq Haddad, is a nationally recognized leader in cardiovascular research. Our national reputation for high quality clinical research allows our patients the ability to participate in cutting-edge research and obtain therapies not otherwise available to them.